Chief Development Officer
Dr. Yendry Ventura brings global experience in immunology, advanced therapeutics, translational medicine, and healthcare leadership. Prior to joining Therakos, he served as Chief Executive Officer of the Abu Dhabi Stem Cells Center (ADSCC), where he led the development of the UAE’s first Bone Marrow Transplant Program, the country’s first CAR-T manufacturing and treatment platform and pioneered Extracorporeal Photopheresis (ECP) programs. As an inventor and Principal Investigator on multiple research initiatives, he has led fundamental, translational, and clinical research programs that have progressed into scalable clinical platforms and innovative therapeutic solutions. Throughout his career, he has built strategic collaborations with leading academic institutions, healthcare organizations, industry partners, and government stakeholders around the world, contributing to the translation of scientific innovation into improved patient care and long-term organizational value.
As Chief Development Officer at Therakos, Dr. Ventura leads business development, strategic partnerships, and value strategy.
Yendry holds a Master of Science in Healthcare Management from Johns Hopkins University and completed his medical and specialty training in immunology at Havana University. He has been widely recognized for his contributions to healthcare innovation, including being named among Forbes Middle East’s Top 100 Healthcare Leaders.